Loading...
The intestinal microbiota determines the clinical efficacy of immune checkpoint blockers targeting PD-1/PD-L1
Cancer immunotherapists have been searching for biomarkers predicting patient responses to PD-1/PD-L1 blockade in neoplastic cells as well as in the immune system. Now, accumulating evidence indicates that the composition of the intestinal microflora has a major impact on patient prognosis. Here, we...
Na minha lista:
| Udgivet i: | Oncoimmunology |
|---|---|
| Main Authors: | , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Taylor & Francis
2018
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5980343/ https://ncbi.nlm.nih.gov/pubmed/29872574 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/2162402X.2018.1434468 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|